Thursday, June 24, 2021

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office

https://www.psychiatrictimes.com/view/patent-brings-psychiatry-one-step-closer-to-precision-medicine